For foreign Emerging Stock Board enterprises, ”*- country of incorporation” indicates stocks without par value or with par value other than NT$10, and ”- country of incorporation” indicates stocks with par value of NT$10 per share.
|
Basic information |
Chairman |
President |
Spokesperson |
Telephone |
Address |
ESM Registration Date |
Fen-Ren Chien |
Shiaw-Min Hwang |
Shiaw-Min Hwang |
02-2697-5599 |
18F-5,No.99,Sec.1,Xintai 5th Rd,Xizhi DistNew Taipei City 221416,Taiwan |
2023/07/20 |
Industrycategory |
Key businesses |
Biotechnology and Medical Care |
U-Neuron Biomedical Inc. was established in 2015, devoted to research and development of new drug of cell therapy and exosomes.
The company’s vision is to be the expert in neurological, aging, and inflammatory diseases based on the core technology: AFSC and AFSC derived secretomes.
Through continuous research, U-NEURON BIOMEDICAL carries out manufacturing that meets clinical specifications, creates new stem cell therapy technologies to fill current medical gaps, and popularizes stem cell technology and cell therapy products through professional technology development and medical research, creating real value of regenerative medicine and a better life for humankind. |
Financial data |
Cash flows statement
| Item
|
|
|
Amount(NTD, in thousands) |
Cash flows from operating activities |
|
|
Cash flows from investing activities |
|
|
Cash flows from financing activities |
|
|
Consolidated/Individual balance sheet
|
Current assets |
|
|
Non-current assets |
|
|
Total assets |
|
|
Current liabilities |
|
|
Non-current liabilities |
|
|
Total liabilities |
|
|
Share capital |
|
|
Capital surplus |
|
|
Retained earnings |
|
|
Other equity interest |
|
|
Treasury shares |
|
|
Total equity attributable to owners of parent |
|
|
Non-controlling interests |
|
|
Total equity |
|
|
Book Value per share(NT$) |
|
|
Consolidated/Individual profit and loss statement |
Operating revenue |
|
|
Operating costs |
|
|
Gross profit from operations |
|
|
Operating expenses |
|
|
Net other income (expenses) |
|
|
Net operating income |
|
|
Non-operating income and expenses |
|
|
Profit before tax |
|
|
Tax expense |
|
|
Profit from continuing operations |
|
|
Profit from discontinued operations |
|
|
Profit |
|
|
Other comprehensive income |
|
|
Comprehensive income |
|
|
Basic earnings per share |
|
|
Auditor's report on latest financial statements: auditor's report:
|
Investors may find more detailed information on the company by visiting the Market Observation Post System.。
|
The information disclosed here concerning foreign enterprises consists of amounts provided in consolidated financial statements.
|